CNO Financial Group filings document the insurance holding company's operating results, governance and capital actions. Form 8-K reports furnish quarterly financial results, financial supplements and operating presentations covering life and health insurance, annuities, distribution activity, investment results and capital management.
Proxy and governance filings address annual meeting voting items, director elections, board committee matters, executive compensation and director compensation. Other material-event reports disclose dividend declarations, board appointments or retirements, Regulation FD presentations and securities identified in the company's capital structure.
CNO Financial Group furnished an 8-K announcing its financial results for the quarter ended September 30, 2025. The company provided a press release, a quarterly financial supplement, and additional financial and operating information, all tied to Q3 2025 performance.
The materials were furnished under Item 2.02 and are not deemed filed for purposes of Section 18 of the Exchange Act. Investors can review the detailed exhibits for the full quarterly narrative and data.
- Exhibit 99.1: Press release (November 3, 2025)
- Exhibit 99.2: Quarterly Financial Supplement – Q3 2025
- Exhibit 99.3: Third Quarter 2025 Financial and Operating Results
- Exhibit 104: Cover Page Inline XBRL
BlackRock, Inc. filed Amendment No. 14 to Schedule 13G reporting beneficial ownership of 12,473,730 shares of CNO Financial Group common stock, representing 12.9% of the class as of the event date 09/30/2025.
BlackRock reports sole voting power over 12,106,902 shares and sole dispositive power over 12,473,730 shares, with no shared voting or dispositive power. The filing states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control. Various persons may have rights to dividends or sale proceeds through managed accounts, but no single person exceeds five percent of the outstanding common shares.
CNO Financial Group, Inc. furnished a Consumer Division Briefing investor presentation dated September 2025. The presentation is attached as Exhibit 99.1 and will also be posted in the Investors section of the company’s website at ir.CNOinc.com. The materials provide information on the company’s consumer division and are being furnished under the Securities Exchange Act of 1934 rather than filed, which affects how they are treated for liability purposes and whether they are incorporated into other SEC documents.
CNO Financial Group director Mary R. Henderson reported a sale of 6,300 shares of CNO common stock on 08/28/2025. The Form 4 shows the disposition was coded as a charitable donation and carried no cash proceeds (price $0). After the reported transaction, Ms. Henderson beneficially owned 73,460 shares in total, held directly.
The filing is a routine Section 16 disclosure by an insider and lists the transaction executor as Heidi M. Krings, Attorney-in-Fact, with a signature date of 08/29/2025. No options, derivatives, or other compensatory transactions are reported on this form.
Karen J. DeToro, President of the Worksite Division at CNO Financial Group (CNO), reported sales of common stock under a Rule 10b5-1 plan adopted May 6, 2025. The filing shows three separate dispositions on August 13-15, 2025 totaling 25,657 shares sold at weighted average prices of approximately $37.96, with reported per-trade weighted averages of $37.9588, $37.9788 and $37.8481. After these sales the reporting person beneficially owned 41,855 shares. The filing indicates the transactions were made pursuant to an affirmative-defense 10b5-1 plan and that detailed per-price breakdowns can be provided upon request.
CNO Financial Group insider filing (Form 4/A) shows that Karen J. DeToro, President of the Worksite Division and an officer of CNO (ticker: CNO), disposed of 1,417 shares of common stock on 01/02/2025. The shares were surrendered to the issuer to cover required tax withholding on vested restricted stock units, at an indicated price of $37.14 per share. Following the transaction, Ms. DeToro beneficially owned 58,918 shares. The filing is an amendment that corrects the amount disposed and the post-transaction beneficial ownership.
CNO Financial Group, Inc. (CNO) Form 144 reports a proposed sale of 9,228 shares of common stock through Morgan Stanley Smith Barney LLC with an aggregate market value of $349,262.27, based on an approximate sale date of 08/15/2025 on the NYSE. The filing lists total shares outstanding of 96,931,934. The securities were acquired as performance shares on 02/14/2023 (7,479 shares) and as restricted stock on 09/30/2021 (1,749 shares). The filer also reported recent sales: 6,509 shares on 08/14/2025 for $247,203.36 and 9,920 shares on 08/13/2025 for $376,551.30. The notice includes the standard representation regarding material nonpublic information and a broker identification.
Form 144 notice for proposed sale of CNO Financial Group, Inc. securities. The filing reports an intended sale of 3,457 common shares with an aggregate market value of $130,845.38. The shares represent part of outstanding common stock of 96,931,934 and the approximate proposed sale date is 08/15/2025 on the NYSE. The 3,457 shares were acquired from the issuer as restricted stock (1,985 shares, 03/25/2024) and performance shares (1,472 shares, 02/15/2024).
Recent sales by the same person are disclosed: Jeanne Linnenbringer sold a total of 11,282 common shares on 08/13/2025 and 08/14/2025 across four trades, generating gross proceeds of $524,457.40 in aggregate as reported. The filer affirms no undisclosed material adverse information and includes standard Rule 144 and Rule 10b5-1 representations.
Jeanne L. Linnenbringer, Chief Operations Officer of CNO Financial Group (CNO), exercised stock options and sold common stock under a 10b5-1 plan. On 08/13/2025 she exercised 4,420 stock options with a $21.06 exercise price, acquiring 4,420 shares. Those shares and additional holdings were sold under a Rule 10b5-1 trading plan adopted May 5, 2025, with reported sales on 08/13/2025, 08/14/2025 and 08/15/2025 at weighted average prices of about $37.96, $37.9794 and $37.8495 respectively. Reported beneficial ownership fell from 45,583 shares after the option exercise to 30,844 shares after the sales. The filing notes vesting of the options (half vested 02/23/2019 and half 02/23/2020).
Gary C. Bhojwani, Chief Executive Officer and Director of CNO Financial Group, Inc. (CNO), reported multiple gifts of company common stock executed on 08/12/2025. The filing shows disposals by gift: 3,092 shares from personal holdings (reported at $0 per share), 5,904 shares from the Gary C. Bhojwani Revocable Trust (reported at $0), and a further 195,926 shares disposed (listed as a disposal). After the reported transactions, the filing records 698,331 shares beneficially owned following the first disposal, held indirectly. The form is signed by an attorney-in-fact on 08/14/2025. All transactions are labeled as gifts in the explanation.